News Chart ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
15.25 ^USD	+0.26%		-10.56%	-51.29%

May. 10	UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating	MT
May. 10	Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating	MT

4761b2761257d09e.L7B8_o3eDbAL3OeP54ndtL0hC3pQ4ZpuqiyDJmGj3NI.HOcwm8HmQvt7nb3dgNCr8vMRfkM319AxnB7hcjfzmORmwDC37LRF3VqTiA~3d4fc695f1e911df7adba7231215541d